Skip to content
← Full study record

NCT00976248 · MORE INFO

Limitations, agreements, and source contact

Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia · Source last updated 2018-10-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
steven_treon@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2681
title
Steven P. Treon, MD, PhD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
steven_treon@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617-632-2681
title
Steven P. Treon, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice